BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | 13.00K | -- | 13.00K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | 13.00K | -- | 13.00K |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | 13.00K | -- | 13.00K |
SG&A Expenses | 19.79M | 2.96M | 1.07M | 2.76M | 4.91M |
Depreciation & Amortization | 554.00K | 21.00K | 30.00K | 31.00K | 49.00K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 20.37M | 2.98M | 1.20M | 2.95M | 5.31M |
Operating Income | -20.37M | -2.98M | -1.18M | -2.95M | -5.29M |
Income Before Tax | -20.37M | -2.80M | -1.10M | -1.91M | -3.91M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -20.37M | -2.80M | -1.10M | -1.91M | -3.91M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -4.00K | -12.00K | 0.00 | -- | -4.00K |
Net Income | -20.37M | -2.81M | -1.10M | -1.91M | -3.92M |
EBIT | -20.37M | -2.98M | -1.18M | -2.95M | -5.29M |
EBITDA | -19.81M | -2.96M | -1.15M | -2.92M | -5.24M |
EPS Basic | -0.74 | -0.14 | -0.07 | -0.12 | -0.30 |
Normalized Basic EPS | -0.46 | -0.09 | -0.04 | -0.11 | -0.26 |
EPS Diluted | -0.74 | -0.14 | -0.07 | -0.12 | -0.30 |
Normalized Diluted EPS | -0.46 | -0.09 | -0.04 | -0.11 | -0.26 |
Average Basic Shares Outstanding | 27.71M | 20.79M | 17.16M | 16.20M | 12.92M |
Average Diluted Shares Outstanding | 27.71M | 20.79M | 17.16M | 16.20M | 12.92M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |